Scherzer & Co — Not feeling the broader market recovery (yet)

Scherzer & Co (DB: PZS)

Last close As at 28/03/2024

3.10

0.02 (0.65%)

Market capitalisation

93m

More on this equity

Research: Financials

Scherzer & Co — Not feeling the broader market recovery (yet)

Scherzer & Co’s (PZS’s) NAV closed H119 flat vs end FY18 and declined 3.5% to the end of August. H119 portfolio performance was dominated by weaker results from GK Software and pre-squeeze-out stagnation in Linde’s share price. These two companies made up c 31% of PZS’s portfolio at the peak in March 2019. €22.8m cash inflow from the Linde squeeze-out allowed for deleveraging and increased PZS’s portfolio of extra compensatory claims (ECS) to €139m. We note that PZS is focused on lesser-known stocks and its short-term performance may at times differ from the broader market.

Milosz Papst

Written by

Milosz Papst

Director, Financials

Financials

Scherzer & Co

Not feeling the broader market recovery (yet)

Asset management

Scale research report - Update

17 September 2019

Price

€2.14

Market cap

€64m

Share price graph

Share details

Code

PZS GY/PZSG

Listing

Deutsche Börse Scale

Shares in issue

29.9m

Last reported net debt at 30 June 2019

€16.5m

Business description

Scherzer & Co (PZS) invests its funds mainly in domestic equities. PZS looks for companies that are unknown or unloved, and special situations. The focus is on special situations, where the downside is perceived to be limited. In addition, it acquires value stocks, mainly below book value. These stocks need to demonstrate strong business models.

Bull

Strong management, well known in the market.

‘Hidden’ NAV driver through special compensatory rights, albeit with binary outcomes.

Well diversified portfolio with attractive risk/return pattern, built over a number of years.

Bear

Dependent on market environment.

Still relatively small.

For the strategy, market size is limited.

Analyst

Milosz Papst

+44 (0) 20 3077 5700

Scherzer & Co’s (PZS’s) NAV closed H119 flat vs end FY18 and declined 3.5% to the end of August. H119 portfolio performance was dominated by weaker results from GK Software and pre-squeeze-out stagnation in Linde’s share price. These two companies made up c 31% of PZS’s portfolio at the peak in March 2019. €22.8m cash inflow from the Linde squeeze-out allowed for deleveraging and increased PZS’s portfolio of extra compensatory claims (ECS) to €139m. We note that PZS is focused on lesser-known stocks and its short-term performance may at times differ from the broader market.

Marginal profit in H119

PZS’s net income came in at a minor €9k in H119, which translated into €0.00 EPS, compared to €0.18 a year earlier. Lower income from trading and dividends was only marginally offset by an improved expense ratio at 1.3% of NAV on a last 12-month (LTM) basis (4.9% a year earlier). The net debt to equity ratio stood at 29%, significantly down from 42% in FY18, supported by cash compensation from the Linde squeeze-out. A minor ECS case was also closed during the period, resulting in €77k income for PZS (including interest).

NAV performance behind broad market

As a result of stagnant NAV performance in H119, PZS lagged both the MDAX and SDAX, which posted a c 20% return in the period. PZS’s portfolio focuses on lesser known/understood stocks, as well as companies in special situations. This means the companies often require company-specific catalysts to materially unlock value and do not always move in line with the broader market, calling for a long-term investment approach. It is also worth noting that in H119, a significant part of the portfolio (c 10–20% between the end of 2018 and March 2019) was ‘locked’ in anticipation of the Linde squeeze-out. PZS’s five-year NAV annual total return to end August 2019 stood at 6.4%.

Valuation: In line with NAV movements

PZS has long traded at a discount to NAV of 15% but, following positive catalysts such as the successful sale of FIDOR Bank in 2016, its shares now trade broadly in line with NAV (currently a 4% discount). An additional stock driver could be the pending AXA ECS case. We estimate that the recent, but not yet final, ruling indicates potential income for PZS of €5.7m ex-interest (or at least €8m including interest). NAV does not include any income from potential ECS profits.

Consensus estimates

Year
end

Revenue
(€m)

PBT
(€m)

EPS
(€)

DPS
(€)

P/E
(x)

Yield
(%)

12/17

17.8

7.9

0.26

0.10

8.2

4.7

12/18

12.1

0.7

(0.03)

0.00

N/A

N/A

12/19e

7.3

4.6

0.16

0.05

13.4

2.3

12/20e

7.6

4.8

0.17

0.05

12.6

2.3

Source: Scherzer & Co, Refinitiv consensus based on three analysts at 6 September 2019.

Edison Investment Research provides qualitative research coverage on companies in the Deutsche Börse Scale segment in accordance with section 36 subsection 3 of the General Terms and Conditions of Deutsche Börse AG for the Regulated Unofficial Market (Freiverkehr) on Frankfurter Wertpapierbörse (as of 1 March 2017). Two to three research reports will be produced per year. Research reports do not contain Edison analyst financial forecasts.

Financials: Weaker trading result and high tax charge

PZS reported a minor net profit of €9k in H119 (H118: €5.3m). The weak result is mostly attributable to lower income from financial instruments of €2.2m (down 71% y-o-y), which reflects lower gains on disposals and from derivatives. At the same time, the negative impact of disposal losses amounted to €1.2m (28% higher y-o-y). Consequently, the overall net result on financial instruments was €1.0m (an 85% decrease y-o-y).

Income from dividends was down to €1.5m vs €2.0m in H118 (a 23% y-o-y decrease). Lower dividend and trading income was only marginally offset by a better result on the portfolio valuation of -€1.4m (vs -€2.0m in H118) and 56% y-o-y lower personnel expenses of €0.3m. The LTM expense ratio was lower at 1.3% of average NAV from 4.9% a year earlier. As a result, EBIT reached €0.4m vs €5.4m in H118.

Net income was negatively affected by an abnormally high income tax charge (€342k vs €23k in H118). We understand that the reasons for the high tax rate were the same as in H218, which was associated with the disposal of stakes in the current portfolio acquired prior to 2017. We explained this in more detail in our last note, highlighting that this tax effect should diminish as a result of regulatory changes.

In the ECS portfolio, PZS reported €71k income from the Strabag case (included in income from financial instruments) and received €22.8m in cash compensation from the Linde squeeze-out, with no impact on profit. Linde shares traded above the squeeze-out price over the notice period and management highlights that if PZS sold its shares in the market (rather than participating in the actual squeeze-out process), it would result in a net gain of €0.9m. We understand that PZS used the cash proceeds to reduce its net debt position to €16.5m (H118: €30.3m), with the current net debt to equity ratio at 29% vs 42% at end 2018 and 48% at end June 2018.

Exhibit 1: FY18 results highlights

€000s, unless otherwise stated

H119

H118

y-o-y

Income from financial instruments

2,193

7,500

-71%

Expenses related to financial instruments

(1,226)

(959)

28%

Result on financial instruments

966

6,541

-85%

Other operating income (excluding value adjustments)

34

0

N/M

Personnel expenses

(308)

(706)

-56%

Other operating expenses

(363)

(389)

-6%

Income from dividends

1,524

1,978

-23%

Unrealized gains (losses)

(1,434)

(2,009)

N/M

D&A

(8)

(4)

N/M

EBIT

410

5,413

-92%

Other interest and similar income

51

49

3%

Interest and similar expenses

(109)

(150)

-27%

EBT

351

5,312

-93%

Income and other taxes

(342)

(23)

1373%

Net profit for the period

9

5,289

-100%

EPS (€)

0.00

0.18

-100%

Source: Scherzer & Co accounts, Edison Investment Research

PZS’s NAV at the end of H119 was the same as at end 2018, with no dividend paid in the period. The LTM total NAV return at end June 2019 was -16.6%, as the value of the portfolio did not rebound following the broader market deterioration in late 2018. Consequently, PZS underperformed the market significantly in H119, as the DAX, MDAX and SDAX posted returns of 17%, 19% and 20% respectively. Including NAV development post balance sheet date, the year-to-date total NAV return (to the end of August 2019) was -3.5%. PZS’s NAV progression (ex-dividends) is shown in Exhibit 2.

Exhibit 2: PZS’s NAV per share and share price comparison (€)

Source: Scherzer & Co accounts

PZS’s current ECS portfolio is not included in the NAV value, but is reflected in NAV on successful closures in the amount of income realised. Returns are at least partially reinvested in the portfolio and contribute to long-term NAV development. During H119, the ECS portfolio expanded by €22.8m to €139m due to the aforementioned squeeze-out at Linde. We note that the ECS portfolio is expressed as the value of compensation received on squeeze-outs. So far this year, only a small transaction at Strabag was concluded. More importantly, in August 2019, the first instance ruling in the AXA 2006 case (the largest ECS held by PZS) confirmed the fair value was above the squeeze-out price. We estimate that if the AXA case was resolved according to first instance ruling, it would translate to a gain for PZS of c €5.7m excluding interest (or at least €8m including interest), which represents a per share amount of €0.19 (or at least €0.27). That said, the current ruling is not final, and it is likely the dispute will be considered in a higher court.

Portfolio developments

Scherzer divides its portfolio into two categories: opportunistic and safe. In either category, PZS focuses on lesser-known companies with limited or no research coverage, as well as companies with business models that are difficult to evaluate which tend to be underappreciated by the broad market. ‘Safe’ companies are characterised by high asset quality with sustainable earnings, whereas the ‘opportunistic’ category consists mostly of companies in special situations such as restructuring or M&A. At end H119, 61% of portfolio was classified as ‘opportunistic’ (FY18: 53%) and 39% as ‘safe’ (FY18: 47%). We believe such a portfolio positioning may in some instances result in a significant diversion from the broader trend in equity markets (as experienced so far this year) and calls for a more long-term investment approach. This year in particular, we see several factors contributing to NAV underperformance.

Firstly, PZS sometimes acquires equity stakes in anticipation of a squeeze-out. There is limited room for price appreciation once the squeeze-out has been announced. A good example of this is PZS’s investment in Linde. The company increased its stake prior to the squeeze-out, which was concluded in April 2019. As a result, the holding represented 21% of PZS’s portfolio at end March 2019 (vs 11% at end 2018). The squeeze-out price of €189.46 per share was approved around mid-December 2018, which limited Linde’s subsequent share price movement, and the majority of cash proceeds from the squeeze-out were used for deleveraging rather than reinvestment. Examples of other stocks included in the portfolio that represent potential squeeze-out candidates are Audi (5.5% of portfolio at end June), Lotto24 (2.6% at end June) and Innogy (2.4% at end August).

GK Software (PZS’s largest holding with 10.2% share at end August 2019) seems to be drifting further away from achieving its targeted 15% EBIT margin by 2020, posting a €5.0m EBIT loss in H119 on the back of product development costs. Also, it recently carried out a €5.1m equity issue at a price of €64 per share. In the case of some other portfolio holdings (eg K+S and freenet), the business headwinds experienced in FY18 seem to have weighed on investor sentiment towards the shares this year, despite an overall stable business performance.

Finally, we note that PZS has a number of less liquid stocks in the portfolio, such as Weleda and AG f. Erstellung billiger Wohnhäuser in Winterthur, which are trading on OTC markets. In addition, PZS holds significant stakes in companies with similar or adjacent business models, eg Allerthal-Werke, RM Rheiner Management and the majority-owned Horus.

Exhibit 3: PZS’s top 10 holdings list

Company

% of total
(Aug 19)

% of total
(Jun 19)

% of total
(Dec 18)

Opportunistic/
safe

GK Software

10.21%

11.88%

11.38%

Opportunistic

freenet

8.12%

7.88%

5.07%

Opportunistic

Audi

5.57%

5.47%

5.15%

Opportunistic

Allerthal-Werke

4.79%

4.74%

4.41%

Safe

Weleda AG PS

4.38%

3.83%

N/A

Opportunistic

Horus

3.87%

3.48%

4.39%

Opportunistic

K+S

3.69%

4.12%

N/A

Opportunistic

AG f. Erstellung billiger Wohnhäuser in Winterthur

3.62%

3.35%

3.24%

Safe

Mobotix

3.60%

4.01%

3.38%

Opportunistic

Innogy

2.37%

N/A

5.18%

Safe

Total top-10 holdings

50.22%

51.33%*

56.03%*

Source: Scherzer & Co, Edison Investment Research. Note: *Includes holdings not in top 10 as at end of August 2019.

Valuation

PZS’s NAV was €2.23 per share at end August 2019 and the current share price of €2.14 implies a 4% discount. Before the favourable Schering ECS ruling in 2015, PZS’s shares tended to trade at a c 15% discount to NAV. PZS realised extra compensation of around 12x the initial investment in Schering and the discount has subsequently tightened close to zero. We believe the Schering ruling improved investor acceptance of potential gains resulting from the ECS portfolio. Nevertheless, there is no visibility on future gains from the ECS portfolio, which may explain why PZS has been trading at a visible discount to the market average based on the P/E ratio.

Exhibit 4: Comparable market P/E ratios (x)

2014

2015

2016

2017

2018

2019e

2020e

DAX

16.6

22.0

19.0

14.6

12.9

14.3

12.5

MDAX

20.0

19.2

28.8

17.6

13.4

19.8

17.9

SDAX

30.9

28.0

23.5

23.4

13.8

19.4

15.2

Arithmetic average

22.5

23.1

23.8

18.5

13.4

17.8

15.2

PZS

11.9

9.2

13.6

10.0

loss

13.9

13.1

PZS discount

47%

60%

43%

46%

N/A

22%

14%

Source: Refinitiv as at 6 September 2019, PZS reports, PZS forecast is Refinitiv consensus based on three analysts. Note: P/E ratios based on year-end prices.

Asset management company valuations are commonly based on asset value, which can be demonstrated by the price to book (P/BV) value. We have analysed the development of P/BV ratios and a decline in PZS’s discount to the market has been apparent since 2015, reaching 17% at end 2018. Since 2017, PZS has mostly traded at a premium to its equity value per share.

Under German reporting standards, NAV development is not fully reflected on the balance sheet. Although a decrease in the market price of the portfolio is reflected through write-offs, increases are only recognised on disposals. The company can only report positive value adjustments by reversing write-offs and in effect the book value of the portfolio cannot exceed the initial investment.

Exhibit 5: Comparable market P/BV ratios (x)

2014

2015

2016

2017

2018

2019e

2020e

DAX

1.7

1.7

1.7

1.9

1.4

1.5

1.4

MDAX

2.1

2.3

1.9

2.1

1.6

1.8

1.7

SDAX

1.9

2.0

1.7

1.8

1.6

1.6

1.5

Arithmetic average

1.9

2.0

1.8

1.9

1.5

1.6

1.5

PZS

0.8

0.8

0.9

1.3

1.3

1.1

1.0

PZS discount

58%

60%

49%

32%

17%

34%

34%

Source: Refinitiv as at 6 September 2019, PZS reports, PZS forecast is Refinitiv consensus based on three analysts. Note: P/BV ratios based on year-end prices.

General disclaimer and copyright

Any Information, data, analysis and opinions contained in this report do not constitute investment advice by Deutsche Börse AG or the Frankfurter Wertpapierbörse. Any investment decision should be solely based on a securities offering document or another document containing all information required to make such an investment decision, including risk factors. This report has been commissioned by Deutsche Börse AG and prepared and issued by Edison for publication globally.

Edison Investment Research standard fees are £49,500 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2019 Edison Investment Research Limited (Edison). All rights reserved FTSE International Limited (“FTSE”) © FTSE 2019. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

The Investment Research is a publication distributed in the United States by Edison Investment Research, Inc. Edison Investment Research, Inc. is registered as an investment adviser with the Securities and Exchange Commission. Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

More on Scherzer & Co

View All

Latest from the Financials sector

View All Financials content

Avon Rubber — Encouraging H219 momentum

In a pre-close statement ahead of Avon Rubber’s FY19 year end, management has indicated the strong momentum in Avon Protection continued through H219. Group performance was also supported by an improved trading environment for milkrite | InterPuls and favourable FX tailwinds. As a result, we have increased our FY19 sales growth estimate to 8% which, after a c £2m one-off non cash tax provision release, leads to a 12.4% increase in our EPS estimate. As the company enters FY20, the momentum is encouraging and should be enhanced when the 3M deal is completed. The shares have performed well since the proposed accretive deal was announced and warrant a premium to UK defence peers.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free